Emily J. Faivre

3.0k total citations
19 papers, 1.1k citations indexed

About

Emily J. Faivre is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Emily J. Faivre has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Genetics and 8 papers in Oncology. Recurrent topics in Emily J. Faivre's work include Estrogen and related hormone effects (9 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Protein Degradation and Inhibitors (6 papers). Emily J. Faivre is often cited by papers focused on Estrogen and related hormone effects (9 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Protein Degradation and Inhibitors (6 papers). Emily J. Faivre collaborates with scholars based in United States and Canada. Emily J. Faivre's co-authors include Carol A. Lange, Andrea R. Daniel, Andrew Skildum, Ming Qiu, Abby L. Olsen, Christopher Hillard, Kathryn B. Horwitz, Julie H. Ostrander, Holly A. Ingraham and Christy R. Hagan and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Emily J. Faivre

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily J. Faivre United States 13 613 578 421 123 107 19 1.1k
Peter R. Reczek United States 20 999 1.6× 571 1.0× 127 0.3× 146 1.2× 109 1.0× 31 1.3k
M. J. Heine France 5 986 1.6× 940 1.6× 176 0.4× 140 1.1× 87 0.8× 5 1.3k
Hany Abdel-Hafiz United States 16 435 0.7× 385 0.7× 264 0.6× 306 2.5× 112 1.0× 24 994
Jeffrey D. Bray United States 12 441 0.7× 224 0.4× 139 0.3× 150 1.2× 56 0.5× 20 885
Shiming Jiang China 18 967 1.6× 332 0.6× 221 0.5× 101 0.8× 178 1.7× 40 1.3k
Lori Sherman United States 6 381 0.6× 633 1.1× 258 0.6× 173 1.4× 81 0.8× 7 926
Cecilia J. Proietti Argentina 22 691 1.1× 327 0.6× 689 1.6× 191 1.6× 298 2.8× 37 1.3k
Nicola Medici Italy 16 475 0.8× 326 0.6× 188 0.4× 89 0.7× 92 0.9× 33 844
Zalman Suldan United States 6 859 1.4× 496 0.9× 209 0.5× 83 0.7× 95 0.9× 6 1.2k
D M Ignar-Trowbridge United States 8 480 0.8× 743 1.3× 280 0.7× 138 1.1× 89 0.8× 9 1.1k

Countries citing papers authored by Emily J. Faivre

Since Specialization
Citations

This map shows the geographic impact of Emily J. Faivre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily J. Faivre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily J. Faivre more than expected).

Fields of papers citing papers by Emily J. Faivre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily J. Faivre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily J. Faivre. The network helps show where Emily J. Faivre may publish in the future.

Co-authorship network of co-authors of Emily J. Faivre

This figure shows the co-authorship network connecting the top 25 collaborators of Emily J. Faivre. A scholar is included among the top collaborators of Emily J. Faivre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily J. Faivre. Emily J. Faivre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Faivre, Emily J., Marybeth A. Pysz, Laura M. Kreckler, et al.. (2024). Abstract 3148: ABBV-706 is a novel SEZ6-targeted topoisomerase 1 inhibitor ADC for SCLC and other neuroendocrine cancers. Cancer Research. 84(6_Supplement). 3148–3148. 1 indexed citations
2.
Sheppard, George S., Le Wang, Lisa Hasvold, et al.. (2018). Abstract 931: Discovery of ABBV-744, a first-in-class highly BDII-selective BET bromodomain inhibitor. Cancer Research. 78(13_Supplement). 931–931.
3.
4.
5.
Lam, Lloyd T., Xiaoyu Lin, Emily J. Faivre, et al.. (2017). Vulnerability of Small-Cell Lung Cancer to Apoptosis Induced by the Combination of BET Bromodomain Proteins and BCL2 Inhibitors. Molecular Cancer Therapeutics. 16(8). 1511–1520. 55 indexed citations
6.
Faivre, Emily J., Denise Wilcox, Xia Li, et al.. (2016). Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075. Molecular Cancer Research. 15(1). 35–44. 53 indexed citations
7.
Faivre, Emily J., Denise M. Wilcox, Paul Hessler, et al.. (2016). Abstract 4694: ABBV-075, a novel BET family inhibitor, disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo. Cancer Research. 76(14_Supplement). 4694–4694. 5 indexed citations
8.
Suzawa, Miyuki, Diego A. Miranda, Emily J. Faivre, et al.. (2015). A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver. eLife. 4. 38 indexed citations
9.
Lee, Florence Y., Emily J. Faivre, Miyuki Suzawa, et al.. (2011). Eliminating SF-1 (NR5A1) Sumoylation In Vivo Results in Ectopic Hedgehog Signaling and Disruption of Endocrine Development. Developmental Cell. 21(2). 315–327. 65 indexed citations
10.
Faivre, Emily J., et al.. (2008). Decreased Recognition of SUMO-Sensitive Target Genes following Modification of SF-1 (NR5A1). Molecular and Cellular Biology. 28(24). 7476–7486. 51 indexed citations
11.
Hagan, Christy R., Emily J. Faivre, & Carol A. Lange. (2008). Scaffolding actions of membrane-associated progesterone receptors. Steroids. 74(7). 568–572. 36 indexed citations
12.
Faivre, Emily J., Andrea R. Daniel, Christopher Hillard, & Carol A. Lange. (2008). Progesterone Receptor Rapid Signaling Mediates Serine 345 Phosphorylation and Tethering to Specificity Protein 1 Transcription Factors. Molecular Endocrinology. 22(4). 823–837. 127 indexed citations
13.
Daniel, Andrea R., Emily J. Faivre, & Carol A. Lange. (2007). Phosphorylation-Dependent Antagonism of Sumoylation Derepresses Progesterone Receptor Action in Breast Cancer Cells. Molecular Endocrinology. 21(12). 2890–2906. 97 indexed citations
14.
15.
16.
Zhang, Ping, Julie H. Ostrander, Emily J. Faivre, et al.. (2004). Regulated Association of Protein Kinase B/Akt with Breast Tumor Kinase. Journal of Biological Chemistry. 280(3). 1982–1991. 57 indexed citations
17.
Skildum, Andrew, Emily J. Faivre, & Carol A. Lange. (2004). Progesterone Receptors Induce Cell Cycle Progression via Activation of Mitogen-Activated Protein Kinases. Molecular Endocrinology. 19(2). 327–339. 118 indexed citations
18.
Pierson-Mullany, Lisa K., et al.. (2003). Cross-Talk Between Growth Factor and Progesterone Receptor Signaling Pathways: Implications for Breast Cancer Cell Growth. Breast Disease. 18(1). 21–31. 10 indexed citations
19.
Qiu, Ming, Abby L. Olsen, Emily J. Faivre, Kathryn B. Horwitz, & Carol A. Lange. (2003). Mitogen-Activated Protein Kinase Regulates Nuclear Association of Human Progesterone Receptors. Molecular Endocrinology. 17(4). 628–642. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter R. Reczek Breakdown of academic impact, for papers by M. J. Heine Breakdown of academic impact, for papers by Hany Abdel-Hafiz Breakdown of academic impact, for papers by Jeffrey D. Bray Breakdown of academic impact, for papers by Shiming Jiang Breakdown of academic impact, for papers by Lori Sherman Breakdown of academic impact, for papers by Cecilia J. Proietti Breakdown of academic impact, for papers by Nicola Medici Breakdown of academic impact, for papers by Zalman Suldan Breakdown of academic impact, for papers by D M Ignar-Trowbridge
Rankless by CCL
2026